Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Raises Price Target to $2

Author: Benzinga Newsdesk | June 06, 2024 10:22am
Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and raises the price target from $1.35 to $2.

Posted In: CDIO